Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Constantine

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Medicinal Chemistry|March 1, 1983
Structure-activity studies of configurationally rigid arylprostaglandinsT K Schaaf, M R Johnson, J W Constantine, et al.
Experientia|August 15, 1977
A tissue-selective prostaglandin E2 analog with potent antifertility effectsH J Hess, J S Bindra, J W Constantine, et al.
European Journal of Pharmacology|February 11, 1994
Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptorsJ W Constantine, W S Lebel, H A Woody, et al.
Journal of Medicinal Chemistry|November 1, 1981
N-(Methanesulfonyl)-16-phenoxyprostaglandincarboxamides: tissue-selective, uterine stimulantsT K Schaaf, J S Bindra, J F Eggler, et al.
Science (New York, N.Y.)|January 25, 1991
A potent nonpeptide antagonist of the substance P (NK1) receptorR M Snider, J W Constantine, J A Lowe, et al.
American Heart Journal|September 1, 1981
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failureC R Taylor, J R Baird, K J Blackburn, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Medicinal Chemistry|March 1, 1983
Structure-activity studies of configurationally rigid arylprostaglandinsT K Schaaf, M R Johnson, J W Constantine, et al.
Experientia|August 15, 1977
A tissue-selective prostaglandin E2 analog with potent antifertility effectsH J Hess, J S Bindra, J W Constantine, et al.
European Journal of Pharmacology|February 11, 1994
Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptorsJ W Constantine, W S Lebel, H A Woody, et al.
Journal of Medicinal Chemistry|November 1, 1981
N-(Methanesulfonyl)-16-phenoxyprostaglandincarboxamides: tissue-selective, uterine stimulantsT K Schaaf, J S Bindra, J F Eggler, et al.
Science (New York, N.Y.)|January 25, 1991
A potent nonpeptide antagonist of the substance P (NK1) receptorR M Snider, J W Constantine, J A Lowe, et al.
American Heart Journal|September 1, 1981
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failureC R Taylor, J R Baird, K J Blackburn, et al.
Pageof 3